Adherence to Anti-Epileptic Drugs and Self-reported Availability and Affordability of the Drugs in Addis Ababa, Ethiopia ======================================================================================================================== * Bethlehem Shawel * Yemane Berhane ## Abstract **Background** Anti-epileptic drugs (AEDs) are the primary therapeutic mode to control seizures in patients with epilepsy. Adherence to the medications is critical to achieving the goals of epilepsy therapy. However, the cost of the drugs and interrupted availability of AEDs contribute to non-adherence to epilepsy treatment. Therefore, this study aimed to assess AED adherence and its association with self-reported drug availability and affordability. **Objective** To assess whether self-reported availability and affordability of Antiepileptic drugs affect drug adherence among Epileptic Patients at Eka Kotebe General Hospital, Addis Ababa, Ethiopia, from January 2023 to March 2023. **Methods** A hospital-based analytical cross-sectional study was conducted among 357 epileptic patients using the Consecutive sampling method in Eka Kotebe General Hospital, Addis Ababa, Ethiopia. AED adherence was measured using a self-report 3items questionnaire focusing on medication use patterns of patients from their last visit to the current visit. Statistical packages for Social Sciences 26.0 version statistical software cleaned, coded and analyzed the collected data. Binary logistic regression was fitted, and P-values less than 0.05 were considered to have statistical significance. **Result** The prevalence of AED adherence was 55.2% with 95% CI (50.1%; 60.2%). About two-thirds (61.3%) of patients in this study had limited access to the AEDs or could not afford the medications. Self-reported availability of AEDs (AOR=2.04, 95% CI=1.03, 4.03) was significantly associated with AED adherence. Self-reported affordability of AEDs was associated with AED adherence (COR=1.59, CI=1.04, 2.42, P-Value=0.031) in the Bivariate logistic regression analysis; however, when adjusted for other covariates in the multivariable logistic regression, no significant association was observed (p=0.730). **Conclusion and Recommendation** Only about half of the epileptic patients adhered to AEDs at Eka Kotebe General Hospital. Self-reported availability of AEDs was an essential factor. Improving access to AEDs is critical to improving adherence and management of epilepsy. ## Introduction Medication adherence is the extent to which individuals take their medications as prescribed with respect to dosage and dosage intervals (1). In both developed and developing countries, non-adherence to medication remains a significant concern for healthcare providers as well as patients because of its adverse consequences on therapeutic outcomes. It is significant, especially in chronic illnesses involving complex and long-term medical regimens (2). Epilepsy is a common chronic neurological disease of the brain affecting 50 million people worldwide, of whom 40 million are estimated to live in developing countries (3). Antiepileptic Drugs (AEDs) are the mainstay of long-term epilepsy treatment, and they are 70% effective at reducing epileptic attacks in adults (4). However, about 90% of epileptic patients in developing countries are not receiving appropriate treatment due to cultural attitudes, lack of prioritization, poor healthcare system, and inadequate supply of antiepileptic drugs (AEDs) (5). In Ethiopia, epilepsy is often mistakenly seen as a form of mental illness by the Community and is usually treated by psychiatrists and psychiatric nurses. The most prescribed Antiepileptic drugs are phenobarbitone, phenytoin, and sometimes carbamazepine and sodium Valproate. A study in Western countries revealed an adherence rate of 71% in the US (6) and 59% in the UK (7). The result was not different in Gondar, Ethiopia (70.8%) (8) and Jimma, Ethiopia (58.5%) (9). On the other hand, the report was higher in India (98.6%) (10) and Palestine (85.3%) (11). However, a lower adherence rate was found in China 51.9% (12), Nigeria (32.6%) (13), and South Africa (54.6%) (14). The consequence of AED nonadherence behavior has been associated with poor seizure control, increased morbidity and mortality along with increased time of hospitalization, worsened patient outcome, poor quality of life, and increased healthcare cost. AED nonadherence will also lead to an increase in the burden of inpatient and emergency department services; moreover, it also affects the family members socially, economically, and psychologically (15). Availability and affordability of AEDs are poor and act as a barrier to accessing treatment for epilepsy in low and middle-income countries (16). In most low-income countries, access to medicines remains very low. The availability and affordability of drugs are two key factors that affect patients’ access to treatment. A study of the availability and prices of AEDs in southern Vietnam showed that only 57% of the public and private pharmacies surveyed had AEDs available (17). A second study conducted in Zambia found that nearly one-half of the government, private, and nongovernmental organization (NGO) pharmacies surveyed did not carry AEDs (18). There is a failure to explore these factors, particularly in Ethiopia. A study done in Bangui, Central African Republic, on the Problem of accessibility to anti-seizure drugs for patients who have epilepsy, shows that the lack of trained personnel, the inadequacy of pharmaceutical structures, the insufficient availability of antiepileptic drugs, and their very high cost are factors limiting the accessibility of antiepileptic medications for epileptic patients (19). This study aimed to evaluate drug availability and affordability from the patient’s point of view. This allows for a more direct assessment of the role of these factors in adherence. However, the studies and tools developed thus far were from a system perspective. Hence, this study aims to assess the association of self-reported drug availability and affordability with drug adherence. In addition, AED adherence was also assessed to fill the gaps in epilepsy treatment. ## Methodology ### Study design and period A hospital-based Analytical cross-sectional study with internal comparison was conducted from January 2023 to March 2023. ### Study Setting The study was conducted at Eka Kotebe General Hospital, located in the eastern part of Addis Ababa, the capital city of Ethiopia. Eka Kotebe General Hospital was established as an extension of Amanuel Mental Specialized Hospital until April 2020, when it became a stand-alone federal hospital. The hospital has a dedicated clinic for patients with epilepsy. There were about 2478 epileptic patients who had regular follow-ups in a year at the outpatient department, and on average, 200 epilepsy patients have follow-ups at the hospital. Patients pay for the services they get from the hospital and for purchasing AEDs, except those who use CBHI (community-based health insurance). The hospital also gives psychiatric services at the outpatient level. In addition, the hospital has served as a dedicated inpatient COVID treatment center. ### Source population Adult epileptic patients who have been on treatment with one or more antiepileptic drugs and who had follow-ups at the outpatient units during the study period. ### Study population We selected adult epileptic patients who have been on treatment with one or more Antiepileptic drugs and who had follow-up at the outpatient units during the study period, fulfilling the inclusion criteria. ### Inclusion criteria Adult Epileptic Patients (age≥18 years) who had a follow-up in the hospital for at least three months and received AEDs at the last visit were eligible for the study. Patients with general severe medical conditions and unable to communicate were excluded. ### Sample Size and Sampling Technique The sample size for the first objective was determined using a single population proportion formula considering the following assumptions (z=1.96, d= 0.05, and P=65%) (20). Second, an attempt was made to calculate the sample size by considering the association of Drug availability and affordability with adherence using Open Epi version 2.3.1. Finally, the sample size we obtained from the first objective was the largest and was taken as our final sample. By considering a non-response rate of 10%, the final estimated sample size was 385. Consecutive sampling was used to recruit samples for the study each day of the data collection process until the desired sample size was obtained. ### Data collection tool and procedures Data was collected using a structured questionnaire translated into a local language (Amharic) and pre-tested. Trained nurses interviewed volunteer participants face-to-face during their follow-up clinic visits. The data was collected after explaining the purpose of the study to the participants and earning informed written consent. The patient interview aimed to gather information related to sociodemographic, clinical factors, psychosocial factors, self-reported drug availability, affordability, and adherence. Their medical records were reviewed for the type of seizure and prescribed AEDs. **Adherence** of epileptic patients to their AEDs was assessed using a self-reported questionnaire; in this study, a 3 items questionnaire focusing on medication use patterns of patients from their last visit to the current visit was used. Patients were asked 3questions: “Did you forget to take your medicine since your last visit?” “In the past two weeks, were there any days you did not take your medicine?” and “Did you take all your medicine yesterday?” The response choices were yes/no, and a response “no” was rated as “1,” and a “yes” response as “0,” except for item 3. For item 3, a response “yes” was rated as “1” and “no” as “0”. The total score ranges from 0 to 3, with scores of